Cell Therapy Catapult CEO appointed to Board of UK BioIndustry Association

Keith Thompson, the CEO of the Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, has been appointed to the Board of the BioIndustry Association, the trade association for bioscience companies in the UK1. The appointment is for three years from the beginning of 2015.

Keith Thompson, CEO of the Cell Therapy Catapult, said, ‘The BIA works tirelessly to make the UK a supportive environment for the growth and development of the life sciences industry and the organisations within it. With the UK cell therapy and regenerative medicine community growing and companies developing new products, I’m delighted to take this Board seat and to help the BIA continue its important efforts.’

1 BIA builds on continued strength with new Board and staff appointments